FIND THE PAIRS
START
i'm ready!
Match the resource with its recommendation or findings. Memorize positions.
2022 EULAR recommendations for screening and
prophylaxis of chronic and opportunistic infections in
adults with autoimmune inflammatory
rheumatic diseases
Risk factors for Pneumocystis jirovecii pneumonia in patients
with rheumatoid arthritis and a prophylactic indication of
trimethoprim/sulfamethoxazole
Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry
When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases
Pneumocystis jiroveci pneumonia prophylaxis is not routinely given in patients with RA, even with simultaneous use of low to moderate doses of prednisone, MTX, and a biologic agent
Prophylaxis recommended when high doses of glucocorticoids are used, especially in combination with immunosuppresants and depending on risk-benefit ratio
Prophylaxis recommended based on scoring system including methotrexate dose, age, immunosuppressant medications, and prednisolone dose
Concomitant use of glucocorticoids was not a predictor of pneumocystis pneumonia
Wrong
Oh no!
Wrong
Memorize the positions and try again
try again
HH:MM:SS
Where is the pair?
2022 EULAR recommendations for screening and
prophylaxis of chronic and opportunistic infections in
adults with autoimmune inflammatory
rheumatic diseases
HH:MM:SS
Where is the pair?
2022 EULAR recommendations for screening and
prophylaxis of chronic and opportunistic infections in
adults with autoimmune inflammatory
rheumatic diseases
Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry
Prophylaxis recommended when high doses of glucocorticoids are used, especially in combination with immunosuppresants and depending on risk-benefit ratio
HH:MM:SS
Where is the pair?
Risk factors for Pneumocystis jirovecii pneumonia in patients
with rheumatoid arthritis and a prophylactic indication of
trimethoprim/sulfamethoxazole
Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry
Concomitant use of glucocorticoids was not a predictor of pneumocystis pneumonia
HH:MM:SS
Where is the pair?
Risk factors for Pneumocystis jirovecii pneumonia in patients
with rheumatoid arthritis and a prophylactic indication of
trimethoprim/sulfamethoxazole
When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases
Prophylaxis recommended based on scoring system including methotrexate dose, age, immunosuppressant medications, and prednisolone dose
HH:MM:SS
Where is the pair?
When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases
Pneumocystis jiroveci pneumonia prophylaxis is not routinely given in patients with RA, even with simultaneous use of low to moderate doses of prednisone, MTX, and a biologic agent
CONGRATULATIONS,YOU'VE "ESCAPED"!
your time
HH:MM:SS
PJP Prophylaxis (2026)
Emmeline Tran
Created on February 23, 2026
Start designing with a free template
Discover more than 1500 professional designs like these:
View
Image Matching Game
View
Corporate Memory Challenge
View
Find the pairs
View
Corporate memory game
View
Memory Game
Explore all templates
Transcript
FIND THE PAIRS
START
i'm ready!
Match the resource with its recommendation or findings. Memorize positions.
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
Risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis and a prophylactic indication of trimethoprim/sulfamethoxazole
Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry
When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases
Pneumocystis jiroveci pneumonia prophylaxis is not routinely given in patients with RA, even with simultaneous use of low to moderate doses of prednisone, MTX, and a biologic agent
Prophylaxis recommended when high doses of glucocorticoids are used, especially in combination with immunosuppresants and depending on risk-benefit ratio
Prophylaxis recommended based on scoring system including methotrexate dose, age, immunosuppressant medications, and prednisolone dose
Concomitant use of glucocorticoids was not a predictor of pneumocystis pneumonia
Wrong
Oh no!
Wrong
Memorize the positions and try again
try again
HH:MM:SS
Where is the pair?
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
HH:MM:SS
Where is the pair?
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry
Prophylaxis recommended when high doses of glucocorticoids are used, especially in combination with immunosuppresants and depending on risk-benefit ratio
HH:MM:SS
Where is the pair?
Risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis and a prophylactic indication of trimethoprim/sulfamethoxazole
Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry
Concomitant use of glucocorticoids was not a predictor of pneumocystis pneumonia
HH:MM:SS
Where is the pair?
Risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis and a prophylactic indication of trimethoprim/sulfamethoxazole
When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases
Prophylaxis recommended based on scoring system including methotrexate dose, age, immunosuppressant medications, and prednisolone dose
HH:MM:SS
Where is the pair?
When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases
Pneumocystis jiroveci pneumonia prophylaxis is not routinely given in patients with RA, even with simultaneous use of low to moderate doses of prednisone, MTX, and a biologic agent
CONGRATULATIONS,YOU'VE "ESCAPED"!
your time
HH:MM:SS